Intellia Therapeutics, Inc.
NTLA
Revenue
6.96M
▼-21.98M▼-75.96%
3 Months ChangeAssets
1.19B
▼-68.05M▼-5.40%
3 Months ChangeLiabilities
220.47M
▼-2.98M▼-1.33%
3 Months ChangeFree Cash Flow
-123.17M
▼-10.01M▼-8.84%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-10-25
Form 8-K
ID: 0001193125-24-244201
2024-08-08
Form 10-Q
ID: 0000950170-24-093907
2024-08-08
Form 8-K
ID: 0000950170-24-093339
2024-06-26
Form 8-K
ID: 0001193125-24-168545
2024-06-14
Form 8-K
ID: 0000950170-24-073709
2024-06-13
Form 8-K
ID: 0000950170-24-073116
2024-05-09
Form 10-Q
ID: 0000950170-24-057046
2024-05-09
Form 8-K
ID: 0000950170-24-056286
2024-04-15
Form 8-K
ID: 0000950170-24-044424
2024-03-22
Form 8-K
ID: 0001193125-24-074706